Why the study?
Do nitrone spin traps and pyrrolidine analogs improve postischemic functional recovery and allow detection of superoxide in isolated ischemic rat hearts?
Do nitrone spin traps and pyrrolidine analogs improve postischemic functional recovery and allow detection of superoxide in isolated ischemic rat hearts?
The phosphonate group in DEPMPO and DEPMPH provides enhanced cardioprotection synergistic with radical trapping, and DEPMPO allows detection of extended superoxide formation during myocardial reperfusion.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for phosphonate-nitronyl synergy in reperfusion injury; leaves open translation to clinical cardioprotection pending further studies.
Formation of free radicals during reperfusion of the isolated ischemic heart has often been demonstrated by detecting hydroxyl radical spin adducts of the nitrone 5,5-dimethyl-1-pyrroline N-oxide (DMPO) in coronary effluents. However, questions still remain regarding (a) whether the reported cardiovascular effects of nitrone perfusion may affect the formation of spin adducts, and (b) the primary generation of superoxide (O2.-), because of the short persistency of O2.-/DMPO spin adduct. We therefore compared the effects of perfusing 5 mM of two nitrones, DMPO and 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline N-oxide (DEPMPO) or the two structurally related pyrrolidines, diethyl (2-methyl-2-pyrrolidinyl) phosphonate (DEPMPH) and pyrrolidine (PyH), on postischemic functional recovery of rat hearts subjected to 10 min of low-flow ischemia, 30 min of global ischemia and 60 min of reperfusion. All compounds were added to the perfusate before ischemia, throughout low-flow ischemia and during the initial 10 min of reflow. In one additional group, hearts received DEPMPO only at reflow. Hemodynamic and in vitro ESR evidence is presented indicating that the phosphonate group of DEPMPO and DEPMPH confers these molecules with an enhanced cardioprotective efficacy, unrelated to radical scavenging, acting in synergy with the intrinsic radical trapping effects of the nitronyl group. Continuous-flow ESR spin trapping using 5.7 mM DEPMPO administered at reflow, but not before ischemia, demonstrated for the first time extended formation of O2.- in the reperfused myocardium.
No takes yet. Share an insight, caveat, or question.
Pietri et al. (1998) studied myocardial reperfusion injury. DMPO, DEPMPO, DEPMPH, and PyH was evaluated on postischemic functional recovery and O2.- formation.
Synapse has enriched 10 related papers. Consider them for comparative context: